Skip to main content
September 16, 2019
Genetic variants associated with left-handedness influence brain connectivity and might be related to the pathogenesis of such neuropsychiatric diseases as Parkinson's disease and schizophrenia, researchers from UK report.
September 13, 2019
Use of a transdermal patch to administer the second-generation anti-psychotic blonanserin improves both positive and negative symptoms of acute schizophrenia with manageable adverse effects, a new industry study shows.
August 22, 2019
Extending olanzapine treatment beyond remission of psychotic-depression symptoms may lower relapse rates, according to findings from the STOP-PD II randomized clinical trial.
August 21, 2019
The use of second-generation antipsychotics (SGAs) is associated with an increased risk of cataracts in people with schizophrenia, researchers report.
August 14, 2019
Deficits in amplitude of the auditory P300 event-related potential, a measure that can be detected by EEG, may be a prognostic biomarker of outcomes in patients with psychosis risk syndrome (PRS), researchers say.
August 14, 2019
Clozapine appears to be more effective for severe schizophrenia than other second- generation antipsychotics (SGAs), but safety concerns remain, a systematic review and meta-analysis suggests.
August 09, 2019
Adjunctive estradiol along with antipsychotic therapy can prompt salutary effects in women of childbearing age with schizophrenia, according to a study conducted in the Republic of Moldavia.
Back to Top